AVBP
Price
$18.95
Change
-$0.16 (-0.84%)
Updated
May 14, 12:17 PM (EDT)
Capitalization
650.26M
LGND
Price
$105.11
Change
-$0.52 (-0.49%)
Updated
May 14, 12:44 PM (EDT)
Capitalization
2.04B
89 days until earnings call
Ad is loading...

AVBP vs LGND

Header iconAVBP vs LGND Comparison
Open Charts AVBP vs LGNDBanner chart's image
ArriVent BioPharma
Price$18.95
Change-$0.16 (-0.84%)
Volume$400
Capitalization650.26M
Ligand Pharmaceuticals
Price$105.11
Change-$0.52 (-0.49%)
Volume$300
Capitalization2.04B
AVBP vs LGND Comparison Chart
Loading...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVBP vs. LGND commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and LGND is a Hold.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (AVBP: $19.10 vs. LGND: $105.63)
Brand notoriety: AVBP and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 72% vs. LGND: 108%
Market capitalization -- AVBP: $650.26M vs. LGND: $2.04B
AVBP [@Biotechnology] is valued at $650.26M. LGND’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, AVBP is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 5 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • AVBP’s TA Score: 5 bullish, 4 bearish.
  • LGND’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than LGND.

Price Growth

AVBP (@Biotechnology) experienced а -3.00% price change this week, while LGND (@Biotechnology) price change was +2.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.30%. For the same industry, the average monthly price growth was +7.19%, and the average quarterly price growth was -5.46%.

Reported Earning Dates

AVBP is expected to report earnings on May 12, 2025.

LGND is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($2.04B) has a higher market cap than AVBP($650M). LGND YTD gains are higher at: -1.419 vs. AVBP (-28.303). AVBP has higher annual earnings (EBITDA): -94.31M vs. LGND (-122.1M). AVBP (219M) and LGND (209M) have equal amount of cash in the bank . AVBP has less debt than LGND: AVBP (176K) vs LGND (4.45M). LGND has higher revenues than AVBP: LGND (181M) vs AVBP (0).
AVBPLGNDAVBP / LGND
Capitalization650M2.04B32%
EBITDA-94.31M-122.1M77%
Gain YTD-28.303-1.4191,995%
P/E RatioN/A46.19-
Revenue0181M-
Total Cash219M209M105%
Total Debt176K4.45M4%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVBPLGND
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OYRDX26.23N/A
N/A
Invesco Rising Dividends Y
ABMIX22.45N/A
N/A
AMG River Road Mid Cap Value I
PABFX17.64N/A
N/A
PGIM Balanced Z
OIEFX23.68N/A
N/A
JPMorgan Equity Income R2
MCTDX9.94N/A
N/A
Modern Capital Tactical Income ADV

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with ETNB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-4.45%
ETNB - AVBP
44%
Loosely correlated
-3.82%
ATXS - AVBP
44%
Loosely correlated
-10.76%
LGND - AVBP
43%
Loosely correlated
-0.71%
LENZ - AVBP
43%
Loosely correlated
-1.40%
ORIC - AVBP
42%
Loosely correlated
-1.85%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with ACLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-0.71%
ACLX - LGND
51%
Loosely correlated
-2.10%
AXON - LGND
49%
Loosely correlated
+4.57%
CRNX - LGND
47%
Loosely correlated
-7.11%
ROIV - LGND
46%
Loosely correlated
-2.09%
SYRE - LGND
45%
Loosely correlated
-1.21%
More